CA-LIGHTBITS-LABS
9.12.2020 14:02:15 CET | Business Wire | Press release
Lightbits Labs today announced advancements to its cloud-native storage solution, enabling customers to confidently scale their private, hybrid, and edge cloud deployments. Lightbits, recently backed by Intel Capital , has extended its solution’s capabilities with the delivery of LightOS™ 2.1. This release further enhances high-performance, scalability, and low latency. Today’s news underpins the Lightbits vision of enabling organizations to unleash hyperscale storage for private clouds, but at a fraction of the cost of even the most advanced cloud storage offerings. LightOS 2.1 further enhances QoS for logical volumes during drive failure recoveries, multi-tenancy capabilities and adds directed-availability of snapshots and thin clones.
The new age of 5G, IoT, AI and ML and ever-increasing analytic data, calls for cloud-optimized block storage volumes that support higher IOPS, higher bandwidth and sub-millisecond, low-variance I/O latency. Like the Amazon EBS io2 Block Express volumes , which was recently announced at the AWS Re:Invent conference, Lightbits Labs’ LightOS provides high-performance, low-latency block storage volumes for on-prem cloud native application environments.
“Lightbits realized early on that disaggregated, high-performance software defined storage that utilized standard Ethernet networking is what would drive successful on-premises cloud deployments,” said Avigdor Willenz, co-founder and chairman of Lightbits Labs and previously co-founder of Annapurna Labs, acquired by Amazon in 2015. “The new Amazon EBS io2 Block Express volumes utilize scalable reliable datagrams that are implemented using custom-built, dedicated hardware. We specifically developed LightOS and NVMe/TCP to avoid the need for special network hardware yet provide a level of performance similar to local NVMe.”
As AWS extends its infrastructure offerings to hybrid cloud with its Outpost offerings, it’s clear that the future of scalable infrastructure is in native cloud practices regardless of where cloud is deployed. For private, hybrid and edge cloud deployments, Lightbits’ LightOS delivers the same or better performance than the latest Amazon EBS io2 Block Express volumes at lower cost. “This enables us to bring high-performance infrastructure for all data centers with our key Intel product portfolio,” said Remi El-Ouazzane, Vice President and Data Platforms Group Chief Strategy and Business Development Officer at Intel. “Given our recent partnership with Lightbits, we’ve had strong customer momentum in the space of disaggregated storage over TCP with customers deploying the solution in production on bare metal edge, enterprise private cloud (financial), and multi-tenancy Kubernetes-based environment for cloud service providers.”
LightOS scale out disaggregated storage solution is perfect for the largest, most performance-sensitive cloud native applications with improved price-performance, ease-of-implementation, availability and scalability. Further, as AWS is now announcing with EBS Gp3 volumes, LightOS has always decoupled IOPS from storage capacity and allowed for independent scaling of storage and compute. When combining this level of performance and flexibility along with other standard features such as thin provisioning, compression, snapshots and thin clones and the ability to utilize and extend the endurance of any flash, including QLC SSDs, it delivers EBS-like “Hyperscale Storage for All” for enterprise private clouds.
Intel’s Remi El-Ouazzane further states: “Our work with Lightbits to optimize the joint solution around Intel® Xeon® Scalable Processors, Optane™ Persistent Memory, 3D NAND QLC SSDs, and Intel® Ethernet 800 Series network adapters has delivered improved performance and TCO for our customer ecosystem.”
LightOS 2.1 is available immediately and offers better performance, scalability and latency than the most advanced cloud offerings for private clouds. With a fully programmatic API, and integration with Kubernetes and OpenStack, and the choice of software-only or a fully integrated and ready-to-run appliance, Lightbits Labs’ LightOS is ready to unleash the full power of private, hybrid and edge clouds for the next 10 years of cloud architecture.
Lightbits Labs Resources
- IDC Research: NVMe/TCP Enables the Democratization of Disaggregated NVMe-based Storage
- Lightbits Labs Hyperscale Storage for All Video
- LightOS 2.0 Product Overview: Software-Defined Composable Storage
- Kubernetes and LightOS: Performance, Persistence, Simplicity
- Apache Kafka and LightOS
About Lightbits Labs™
Lightbits Labs “Hyperscale Storage for All” delivers composable NVMe/TCP storage that enables on-premise, hybrid cloud, and cloud native environments to independently scale storage from compute thereby unleashing hyperscale flexibility while lowering cost and performing like local flash. The highly available software-defined storage maximizes utilization, helping customers maintain operational efficiency and easily scale their business.
Founded in 2016, Lightbits pioneered NVMe/TCP and delivered the industry’s first NVMe/TCP storage solution. Lightbits is backed by strategic investors including Intel Capital, Dell Technologies Capital, Cisco Investments, and Micron, as well as top investors and VCs including Avigdor Willenz, Lip-Bu Tan, Marius Nacht, SquarePeg Capital, and WRVI Capital. Learn more at www.lightbitslabs.com or contact us at info@lightbitslabs.com .
Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201209005065/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release
Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
